According to a team from the Everyman Centre at The Institute, UK, the majority of prostate cancers are essentially harmless - also known as “pussycat” prostate cancers, but it can often be difficult to distinguish them from the harmful ones, known as “tigers”.
Researchers suggests that there is a real need to find a way of […]

continue reading from " A Proposal To Ignore “pussycat” Prostate Cancer "

According to Chicago Department of Public Health, prostate cancer is very survivable because it’s a very treatable disease.
But depending on the type of treatment selected, a prostate cancer patient can suffer some rather uncomfortable side effects, among them impotence and incontinence.
Surgery that removes the tumor can result in impotence, if the nerves that control erection […]

continue reading from " Treatment Options Are Many for Prostate Cancer "

More than 95 per cent of men who took degarelix for prostate cancer saw their testosterone levels fall dramatically as early as three days after they started treatment, according to a paper in the December issue of BJU International.
They also experienced much greater falls in their prostate-specific antigen (PSA) levels at 14 and 28 days […]

continue reading from " Prostate cancer drug reduces testosterone levels in as little as 3 days "

The Prostate Cancer Charity is launching a new strategy ‘Transforming The Future For Prostate Cancer’ - which it believes could reduce mortality rates by 30 per cent.
The strategy, which has been unveiled at a special event last Monday (1 December), outlines ambitious goals and targets for vital changes the Charity believes are necessary to improve men’s experience of […]

continue reading from " Transforming The Future For Prostate Cancer "

Prostate cancer – and perhaps other cancers – develops more aggressive tumors by promoting growth of new nerves and the branching axons that carry their messages, said researchers from Baylor College of Medicine in the first report of the phenomenon that appears today in the journal Clinical Cancer Research.
Previous research showed that prostate cancer follows the growth of nerves. […]

continue reading from " Prostate cancer spurs new nerves "

One of the most dread terms feared by man is Prostate Cancer.  Perhaps it is not so much of the fear of cancer, but more so the psychological fear of losing his manhood or vigility. 
I was pleasantly delighted the other day by what one doctor told us in a seminar.  She quipped and I quoted […]

continue reading from " Prostate Cancer, A Frightening Diagnosis But Not a Death Sentence! "

A new vaccine principle is being developed by scientists at the University of Copenhagen which if it works to its full expected potential could help to save millions of lives and revolutionise current vaccine technology.
The ‘InVacc’ platform, as it is known, represents an advance on the original DNA vaccines and generates new vaccines with greatly […]

continue reading from " New cancer “vaccine” technology makes progress "

The glucose-regulated protein GRP78 has been identified as a crucial entity in the development of prostate cancer by promoting cancer cell proliferation, mediating oncogenic signaling and protecting cancer cells against cell death resulting from the stress of tumor development.
With the recent advances researchers hope that therapy may open up an entirely new approach to stop human cancer.

continue reading from " Researchers found that they could block prostate cancer "

There are more men being diagnosed with prostate cancer in New York State now than there were in the 1980s.
It is believed that most of the increase has been due to more screening for prostate cancer. The Prostate Specific Antigen (PSA) test can identify very early cases of prostate cancer, many years before they would […]

continue reading from " In the number of men with prostate cancer increasing? "

Researchers at Vanderbilt University have found that the use of aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs) is significantly associated with lower PSA (prostate-specific antigen) levels, especially among men with prostate cancer.
The study will be presented at the American Association for Cancer Research’s Seventh Annual International Conference on Frontiers in Cancer Prevention Research

continue reading from " Aspirin may cut prostate cancer risk "